毒性試験アウトソーシング市場：方法、業務タイプ、最終用途別-2025-2030年の世界予測

毒性試験アウトソーシング市場の2023年の市場規模は39億7,000万米ドルで、2024年には43億1,000万米ドルに達すると予測され、CAGR 9.03％で成長し、2030年には72億8,000万米ドルに達すると予測されています。

毒性試験アウトソーシングの範囲では、化学物質、医薬品、その他の物質の安全性や潜在的な有害影響を評価する試験を実施するために、外部の研究所やサービスプロバイダーと契約することが含まれます。このアプローチは、企業が厳しい規制要件を遵守し、コストを管理し、社内にない専門知識を利用する必要性から必要とされています。最終用途は、医薬品、農薬、バイオテクノロジー、消費財などの業界で、医薬品、化粧品、飲食品、環境分析などが含まれます。市場成長の原動力は、研究開発費の増加、検査手法の技術的進歩、化学物質の安全性と環境への影響に対する意識の高まりです。さらに、動物を使わない試験への移行や、毒性予測やハイスループットスクリーニングの重視は、技術革新や継続的研究に新たな道を開くものです。また、規制の枠組みが厳しくなりつつある新興国市場の拡大も、専門家によるサービスに対する需要を後押ししています。

しかし、いくつかの課題が市場拡大を妨げています。規制上の障害、動物実験に関する倫理的懸念、高度な検査技術の高コストなどです。さらに、地域によって規制が異なるため、世界な事業展開が複雑化する可能性があり、さまざまな管轄区域に適応可能でコンプライアンスに準拠した試験ソリューションが必要となります。こうした課題にもかかわらず、毒性予測モデルにおける人工知能や機械学習の統合、パートナーシップや協力関係の拡大など、技術主導のイノベーションに投資することで、市場の成長を促進することができます。

企業は、in vitro、in silico、代替試験法における革新的な開発、エネルギー効率とコスト効率の高いプロセス、毒性予測におけるバイオテクノロジーの活用を優先し、優位に立つべきです。市場はダイナミックで、技術の進歩や規制状況の変化とともに進化しているため、新たな動向や法改正をいち早く把握するための継続的なモニタリングと適応の必要性が強調されます。研究コンソーシアムに参加することで、知識の共有がさらに促進され、ネットワーク全体で業界標準の進歩が促進され、事業の持続的成長が確保されます。

市場力学：急速に進化する毒性試験アウトソーシング市場の主要市場インサイトを公開

毒性試験アウトソーシング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 動物実験に関する倫理的問題の高まり
  • 創薬と個別化医療への注目の高まり
  • 毒性データベースの増加
• 市場抑制要因
  • 生体内条件の複雑さを確立するための基準の欠如
• 市場機会
  • 3D細胞培養システムの進化に伴う毒性試験サービスの受け入れ拡大
  • 安全性の時間節約パラメータに起因する毒性アッセイの広範な採用
• 市場の課題
  • 毒性試験手順の訓練を受けた専門家の不足

ポーターの5つの力：毒性試験アウトソーシング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：毒性試験アウトソーシング市場における外部からの影響の把握

外部マクロ環境要因は、毒性試験アウトソーシング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析毒性試験アウトソーシング市場における競合情勢の把握

毒性試験アウトソーシング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス毒性試験アウトソーシング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、毒性試験アウトソーシング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨毒性試験アウトソーシング市場における成功への道筋を描く

毒性試験アウトソーシング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 動物実験に関する倫理的問題の高まり
    • 創薬と個別化医療への注目が高まる
    • 毒性データベースの増加
  • 抑制要因
    • 生体内の複雑な状況を確立するための基準の欠如
  • 機会
    • 3D細胞培養システムの進化により毒性試験サービスの受け入れが拡大
    • 安全性と時間を節約するパラメータに起因する毒性試験の広範な採用
  • 課題
    • 毒性試験手順に関する訓練を受けた専門知識の欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 毒性試験アウトソーシング市場：方法別

• 試験管内毒性試験
• 生体内毒性試験

第7章 毒性試験アウトソーシング市場診療タイプ別

• 優良試験所基準（GLP）
• 非GLP

第8章 毒性試験アウトソーシング市場：最終用途別

• 学術調査機関
• 製薬・バイオ医薬品企業

第9章 南北アメリカの毒性試験アウトソーシング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の毒性試験アウトソーシング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの毒性試験アウトソーシング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Biognosys AG
• BioIVT, LLC
• Catalent, Inc.
• Charles River Laboratories International, Inc.
• Danaher Corporation
• Eagle Analytical
• Eurofins Scientific Limited
• Evotec SE
• Laboratory Corporation of America Holdings
• Lonza Group Ltd.
• Merck KGaA
• Perkinelmer Inc.
• Promega Corporation
• Qiagen N.V.
• Quest Diagnostics Incorporated
• SGS S.A.
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. TOXICITY TESTING OUTSOURCING MARKET RESEARCH PROCESS
• FIGURE 2. TOXICITY TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TOXICITY TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TOXICITY TESTING OUTSOURCING MARKET DYNAMICS
• TABLE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VITRO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN-VIVO TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GOOD LABORATORY PRACTICES (GLP), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NON-GLP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 27. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 44. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 47. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 99. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 110. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 111. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 114. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PRACTICE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 143. TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 144. TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

The Toxicity Testing Outsourcing Market was valued at USD 3.97 billion in 2023, expected to reach USD 4.31 billion in 2024, and is projected to grow at a CAGR of 9.03%, to USD 7.28 billion by 2030.

The scope of toxicity testing outsourcing involves contracting external laboratories and service providers to conduct tests assessing the safety and potential harmful effects of chemicals, pharmaceuticals, and other substances. This approach is necessitated by the need for organizations to comply with stringent regulatory requirements, manage costs, and access specialized expertise not available in-house. It finds application across industries such as pharmaceuticals, agrochemicals, biotechnology, and consumer goods, with end-use sectors including pharmaceuticals, cosmetics, food and beverage, and environmental analysis. Market growth is driven by increasing R&D expenditures, technological advancements in testing methodologies, and heightened awareness of chemical safety and environmental impact. Additionally, the move towards animal-free testing and emphasis on predictive toxicity and high-throughput screening open fresh avenues for innovation and ongoing research. Opportunities also arise from expanding markets in emerging economies where regulatory frameworks are becoming more stringent, thereby fueling demand for expert services.

However, several challenges impede market expansion. These include regulatory hindrances, ethical concerns regarding animal testing, and the high cost of advanced testing technologies. Moreover, varying regional regulations can create complexities for global operations, necessitating adaptable and compliant testing solutions across different jurisdictions. Despite these challenges, investing in technology-driven innovations, such as artificial intelligence and machine learning integration in toxicity prediction models and expanding partnerships and collaborations, can catalyze market growth.

Firms should prioritize innovative development in in vitro, in silico, and alternative testing methods, energy-efficient and cost-effective processes, and use of biotechnology in toxicity forecasting to edge ahead. The market is dynamic, evolving with technological progress and shifting regulatory landscapes, thus emphasizing the need for continuous monitoring and adaptation to identify emerging trends and legislative changes promptly. Engaging in research consortia can further facilitate knowledge sharing and drive industry-standard advancements across networks, ensuring sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Toxicity Testing Outsourcing Market

The Toxicity Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising ethical issues about animal testing
  • Increasing focus on drug discovery and personalized medicine
  • Growing number of toxicity databases
• Market Restraints
  • Lack of standards to establish intricacies of in-vivo conditions
• Market Opportunities
  • Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
  • Extensive adoption of toxicology assays attributed to safety time-saving parameters
• Market Challenges
  • Lack of trained expertise for the toxicity testing procedure

Porter's Five Forces: A Strategic Tool for Navigating the Toxicity Testing Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Toxicity Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Toxicity Testing Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Toxicity Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Toxicity Testing Outsourcing Market

A detailed market share analysis in the Toxicity Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Toxicity Testing Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Toxicity Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Toxicity Testing Outsourcing Market

A strategic analysis of the Toxicity Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Toxicity Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, BioIVT, LLC, Catalent, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Eagle Analytical, Eurofins Scientific Limited, Evotec SE, Laboratory Corporation of America Holdings, Lonza Group Ltd., Merck KGaA, Perkinelmer Inc., Promega Corporation, Qiagen N.V., Quest Diagnostics Incorporated, SGS S.A., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Toxicity Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Method, market is studied across In-Vitro toxicity testing and In-Vivo toxicity testing.
• Based on Practice Type, market is studied across Good Laboratory Practices (GLP) and Non-GLP.
• Based on End-Use, market is studied across Academic & Research Institutes and Pharmaceutical & Biopharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising ethical issues about animal testing
    • 5.1.1.2. Increasing focus on drug discovery and personalized medicine
    • 5.1.1.3. Growing number of toxicity databases
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standards to establish intricacies of in-vivo conditions
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing acceptance of toxicity testing services with the evolution of 3D cell culture systems
    • 5.1.3.2. Extensive adoption of toxicology assays attributed to safety time-saving parameters
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of trained expertise for the toxicity testing procedure
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Toxicity Testing Outsourcing Market, by Method

• 6.1. Introduction
• 6.2. In-Vitro toxicity testing
• 6.3. In-Vivo toxicity testing

7. Toxicity Testing Outsourcing Market, by Practice Type

• 7.1. Introduction
• 7.2. Good Laboratory Practices (GLP)
• 7.3. Non-GLP

8. Toxicity Testing Outsourcing Market, by End-Use

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Pharmaceutical & Biopharmaceutical Companies

9. Americas Toxicity Testing Outsourcing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Toxicity Testing Outsourcing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Toxicity Testing Outsourcing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Biognosys AG
• 5. BioIVT, LLC
• 6. Catalent, Inc.
• 7. Charles River Laboratories International, Inc.
• 8. Danaher Corporation
• 9. Eagle Analytical
• 10. Eurofins Scientific Limited
• 11. Evotec SE
• 12. Laboratory Corporation of America Holdings
• 13. Lonza Group Ltd.
• 14. Merck KGaA
• 15. Perkinelmer Inc.
• 16. Promega Corporation
• 17. Qiagen N.V.
• 18. Quest Diagnostics Incorporated
• 19. SGS S.A.
• 20. Thermo Fisher Scientific, Inc.